Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 09-000047
NCT ID: NCT01500902
Sponsor Protocol Number: 09-000047
About this study
The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study participants will undergo mental stress testing while at the same time being connected to a device that measures endothelial function via the Endopat device. These same participants will also undergo a sleep study via the Watchpat device.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients undergoing revascularization by percutaneous intervention (PCI) for Acute Coronary Syndrome (ACS) at Mayo (STEMI and NonSTEMI patients)
- Age greater than 18
Exclusion Criteria:
- Patients likely not to complete the study due to co-morbid conditions (end stage renal disease; liver failure; malignancies)
- Inability to sign a consent form or availability for follow up
- Patients unable to tolerate the blood pressure cuff inflation on both arms
- patients with tremors
- sustained non-sinus cardiac arrhythmias
- acrylic finger nails
- permanent pacemaker
- color blindness
- use of alpha blockers and short acting nitrates < 3 hours before study
- Federal Medical Center inmates
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Amir Lerman, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available